DBV Technologies (NASDAQ:DBVT) Trading Up 6.8%


Share on StockTwits

Shares of DBV Technologies S.A. (NASDAQ:DBVT) were up 6.8% on Thursday . The stock traded as high as $6.01 and last traded at $5.96. Approximately 318 shares traded hands during trading, a decline of 100% from the average daily volume of 678,058 shares. The stock had previously closed at $5.58.

Several research analysts have weighed in on DBVT shares. Citigroup raised their price objective on shares of DBV Technologies from $4.00 to $8.00 in a report on Friday, January 15th. SVB Leerink reaffirmed an “outperform” rating on shares of DBV Technologies in a report on Friday, March 12th. Zacks Investment Research raised shares of DBV Technologies from a “sell” rating to a “hold” rating in a report on Friday, April 2nd. Societe Generale lowered shares of DBV Technologies from a “hold” rating to a “sell” rating in a report on Friday, January 22nd. Finally, The Goldman Sachs Group lifted their price target on shares of DBV Technologies from $4.00 to $7.00 in a report on Monday, January 18th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $7.11.

The stock has a market capitalization of $657.04 million, a P/E ratio of -2.56 and a beta of 2.91. The company’s 50-day moving average is $5.47 and its two-hundred day moving average is $3.66. The company has a current ratio of 4.28, a quick ratio of 4.22 and a debt-to-equity ratio of 0.08.

A number of large investors have recently modified their holdings of DBVT. US Bancorp DE lifted its position in DBV Technologies by 687.5% in the 4th quarter. US Bancorp DE now owns 11,576 shares of the company’s stock valued at $30,000 after purchasing an additional 10,106 shares during the last quarter. Mercer Global Advisors Inc. ADV bought a new stake in DBV Technologies in the 3rd quarter valued at about $35,000. Janney Montgomery Scott LLC bought a new stake in DBV Technologies in the 4th quarter valued at about $77,000. Jane Street Group LLC lifted its position in DBV Technologies by 420.7% in the 3rd quarter. Jane Street Group LLC now owns 66,064 shares of the company’s stock valued at $114,000 after purchasing an additional 53,377 shares during the last quarter. Finally, Norges Bank bought a new stake in DBV Technologies in the 4th quarter valued at about $131,000. Hedge funds and other institutional investors own 32.49% of the company’s stock.

About DBV Technologies (NASDAQ:DBVT)

DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults.

Recommended Story: Discover Your Risk Tolerance

Receive News & Ratings for DBV Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV Technologies and related companies with MarketBeat.com's FREE daily email newsletter.